Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization

Shuhei Fukunaga(Kurume University), Takuji Torimura(Omuta hospital), Hidetoshi Takedatsu(Kurume University), Ryosuke Yamauchi(Kurume University), Shinichiro Yoshioka(Kurume University), Hiroshi Yamasaki(Museum für Naturkunde), Tatsuyuki Kakuma(Kurume University), Atsushi Mori(Kurume University), Kotaro Kuwaki(Kurume University), Osamu Tsuruta(Kurume University), Keiichi Mitsuyama(Kurume University)
International Journal of Molecular Medicine
November 7, 2017
10.3892/ijmm.2017.3244
Cited by 75

Related Papers

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600